Search research articles
Contact Us
Filters
Showing results (21-30 of 268) with videos related to
Page
of 27
Sort By:
Urologie (Heidelberg, Germany)
|
October 13, 2023
[Primary staging with PSMA-PET improves the prediction of prostate cancer recurrence]
Leubet Yirga, Boris Hadaschik, Lukas Püllen
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 15, 2024
The DETECT Trial: Are We on the Verge of Precision Surgery in Primary Prostate Cancer?
Tobias Maurer, Christian Thomas, Boris Hadaschik
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 25, 2025
<sup>177</sup>Lu-PSMA-617 Monotherapy Is Provocative but No Standard of Care for Metastatic Hormone-Sensitive Prostate Cancer
Boris Hadaschik, Silke Gillessen, Oliver Sartor
European Urology Focus
|
December 22, 2021
Reply to Nikolaos Grivas, Nikolaos Kalampokis, Markos Karavitakis, Ioannis Leotsakos, Ioannis Katafigiotis, and Henk van der Poel's Letter to the Editor re: Bara Barakat, Hazem Othman, Ulrich Gauger, Ingmar Wolff, Boris Hadaschik, Christian Rehme. Retzius Sparing Radical Prostatectomy Versus Robot-assisted Radical Prostatectomy: Which Technique Is More Beneficial for Prostate Cancer Patients (MASTER Study)? A Systematic Review and Meta-analysis. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2021.08.003
Bara Barakat, Christian Rehme, Boris Hadaschik
European Urology
|
February 23, 2022
Re: Abiraterone Acetate and Prednisolone With or Without Enzalutamide for High-risk Non-metastatic Prostate Cancer: A Meta-analysis of Primary Results from Two Randomized Controlled Phase 3 Trials of the STAMPEDE Platform Protocol
Viktor Grünwald, Carsten-Henning Ohlmann, Boris Hadaschik
European Urology Open Science
|
April 14, 2025
Screening for Prostate Cancer with Prostate-specific Antigen
Rouvier Al-Monajjed, Peter Albers, Boris Hadaschik
Aktuelle Urologie
|
February 9, 2021
[Local and metastasis-directed therapy for oligometastatic prostate cancer]
Lukas Püllen, Tanja Sprave, Boris Hadaschik, et al.
Current Genomics
|
July 23, 2008
The role of stress proteins in prostate cancer
Alan So, Boris Hadaschik, Richard Sowery, et al.
Urologie (Heidelberg, Germany)
|
December 16, 2022
[Photodynamic TUR-B: it looks better than it is : Comment on the randomized study]
Leubet Yirga, Boris Hadaschik, Maximilian Burger, et al.
Der Radiologe
|
February 14, 2020
[What does the nonradiologist expect from the radiologist?]
Stefan Kasper, Isabel Virchow, Boris Hadaschik, et al.
Page
of 27
Search research articles
Search
Showing results (21-30 of 268) with videos related to
Sort By:
Page
of 27
Urologie (Heidelberg, Germany)
|
October 13, 2023
[Primary staging with PSMA-PET improves the prediction of prostate cancer recurrence]
Leubet Yirga, Boris Hadaschik, Lukas Püllen
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 15, 2024
The DETECT Trial: Are We on the Verge of Precision Surgery in Primary Prostate Cancer?
Tobias Maurer, Christian Thomas, Boris Hadaschik
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 25, 2025
<sup>177</sup>Lu-PSMA-617 Monotherapy Is Provocative but No Standard of Care for Metastatic Hormone-Sensitive Prostate Cancer
Boris Hadaschik, Silke Gillessen, Oliver Sartor
European Urology Focus
|
December 22, 2021
Reply to Nikolaos Grivas, Nikolaos Kalampokis, Markos Karavitakis, Ioannis Leotsakos, Ioannis Katafigiotis, and Henk van der Poel's Letter to the Editor re: Bara Barakat, Hazem Othman, Ulrich Gauger, Ingmar Wolff, Boris Hadaschik, Christian Rehme. Retzius Sparing Radical Prostatectomy Versus Robot-assisted Radical Prostatectomy: Which Technique Is More Beneficial for Prostate Cancer Patients (MASTER Study)? A Systematic Review and Meta-analysis. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2021.08.003
Bara Barakat, Christian Rehme, Boris Hadaschik
European Urology
|
February 23, 2022
Re: Abiraterone Acetate and Prednisolone With or Without Enzalutamide for High-risk Non-metastatic Prostate Cancer: A Meta-analysis of Primary Results from Two Randomized Controlled Phase 3 Trials of the STAMPEDE Platform Protocol
Viktor Grünwald, Carsten-Henning Ohlmann, Boris Hadaschik
European Urology Open Science
|
April 14, 2025
Screening for Prostate Cancer with Prostate-specific Antigen
Rouvier Al-Monajjed, Peter Albers, Boris Hadaschik
Aktuelle Urologie
|
February 9, 2021
[Local and metastasis-directed therapy for oligometastatic prostate cancer]
Lukas Püllen, Tanja Sprave, Boris Hadaschik, et al.
Current Genomics
|
July 23, 2008
The role of stress proteins in prostate cancer
Alan So, Boris Hadaschik, Richard Sowery, et al.
Urologie (Heidelberg, Germany)
|
December 16, 2022
[Photodynamic TUR-B: it looks better than it is : Comment on the randomized study]
Leubet Yirga, Boris Hadaschik, Maximilian Burger, et al.
Der Radiologe
|
February 14, 2020
[What does the nonradiologist expect from the radiologist?]
Stefan Kasper, Isabel Virchow, Boris Hadaschik, et al.
Page
of 27